Medical Communications
Mundipharma and Cidara Therapeutics report positive Phase III results into candidemia treatment
April 26, 2022 Medical Communications
Mundipharma and Cidara Therapeutics have presented data from the Phase III ReSTORE trial of rezafungin, in the treatment of candidemia …
Vivesto signs agreement with CRO to evaluate anti-cancer drug formulations
April 22, 2022 Medical Communications
Vivesto AB, an oncology-focused pharmaceutical company, has announced that it is advancing research into its proprietary drug delivery formulations, and …
Orasis Pharmaceuticals announces positive Phase III results of eye drop candidate
April 22, 2022 Medical Communications
Orasis Pharmaceuticals has announced that the Phase III NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of …
FDA approves Phase III Acute Respiratory Distress Syndrome (ARDS) Trial
April 22, 2022 Medical Communications
The FDA has approved Direct Biologics to proceed with its Phase III clinical trial into the treatment of Acute Respiratory …
WHO “strongly recommends” Paxlovid, calls for wide distribution from Pfizer
April 22, 2022 Medical Communications
WHO has endorsed the use of Pfizer’s oral antiviral treatment for high-risk patients with mild COVID-19, following an analysis of …
NICE publishes guidance for atopic dermatitis treatments
April 8, 2022 Medical Communications
Abrocitinib, upadacitinib, and tralokinumab are not recommended for treating moderate to severe atopic dermatitis. The recommendation does not affect patients …
First-of-its-kind vaccine manufacturing facility shipped to Africa
April 8, 2022 Medical Communications
KeyPlants announced the shipping a first-of-its-kind vaccine manufacturing filling facility to Senegal, in West Africa.
Acadia seeks first-ever FDA approval in Rett Syndrome
April 8, 2022 Medical Communications
Acadia has presented an update on its Phase III LAVENDER study of trofinetide for Rett Syndrome at the American Academy …
FlyPharma Conference Europe: New dates and location announced
April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
FDA places two clinical holds on CytoDyn HIV and COVID-19 programmes
April 1, 2022 Medical Communications
The FDA has placed a partial hold on CytoDyn’s HIV program, and a full clinical hold on its COVID-19 program …
Biomodex launches clear cartridges for neurovascular training
April 1, 2022 Medical Communications
Biomodex has announced the launch of clear cartridges for use with Biomodex’s EVIAS and EVIAS Plus stations.The cartridges are 3D …
Isturisa effective in treating rare Cushing’s disease
April 1, 2022 Medical Communications
Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy …
UK app launched for people living with glaucoma
April 1, 2022 Medical Communications
Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …
After pressure from patients, ALS drug reviewed by FDA
March 25, 2022 Medical Communications
The FDA is meeting next week to review a drug closely watched for ALS, also known as Lou Gehrig’s disease, …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
